Lazard Inc (LAZ)
NYSEFinancialsCapital MarketsSnapshot 2026-07-31
Reading LAZ? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →NYSEFinancialsCapital MarketsSnapshot 2026-07-31
Reading LAZ? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Investment Banking & Brokerage is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Improve cash from operating activities toward positive levels: -219M vs >0M.
View ThesisRevenue is growing steadily — about 9% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 31% in its worst 12-month stretch.
View RiskLazard's growth in Asset Management must continue to justify its current price. Revenue grew 1% year over year, but the last quarter missed expectations. It trades at 22× P/E versus a peer median of 21×. This suggests the price reflects less growth than forecasted. The primary risk is improving cash from operating activities, which is currently negative at -219 million. Peer multiples imply a price about 8% above where it trades. This read is provisional.
Trailing returns as of 2026-07-31. LAZ is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 10 analysts currently covering LAZ (as of Jul 2026).
Based on 4 Wall Street analysts offering 12-month price targets for LAZ in the last 4 months.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Investment Banking & Brokerage — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Advances: Grow Asset Management business and AUM
New executives enhance leadership for Asset Management growth.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
Current $42.38
The last 12 months of price, then the range of analyst 12-month targets from today’s $42.38.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Advances: Grow Asset Management business and AUM
Talent acquisition boosts Asset Management capabilities and AUM growth.

Threatens: Complete strategic acquisitions
PE deal shortfall impacts strategic acquisition goals.

Threatens: Improve cash from operating activities
Earnings drop threatens cash from operating activities objective.
Threatens: Improve cash from operating activities
Significant net income drop raises concerns about cash flow.
Advances: Complete strategic acquisitions
Targets $10m per MD aligns with strategic growth objective.

Threatens: Improve cash from operating activities
Profit decline affects cash from operating activities.

Threatens: Improve cash from operating activities
Profit decline affects cash from operating activities.
